A detailed history of Westside Investment Management, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Westside Investment Management, Inc. holds 7,500 shares of BMY stock, worth $431,850. This represents 0.08% of its overall portfolio holdings.

Number of Shares
7,500
Previous 7,493 0.09%
Holding current value
$431,850
Previous $311 Million 24.23%
% of portfolio
0.08%
Previous 0.07%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 20, 2024

BUY
$39.66 - $51.75 $277 - $362
7 Added 0.09%
7,500 $387 Million
Q2 2024

Jul 17, 2024

BUY
$40.25 - $52.99 $29,463 - $38,788
732 Added 10.83%
7,493 $311 Million
Q1 2024

Apr 19, 2024

SELL
$47.98 - $54.4 $18,952 - $21,488
-395 Reduced 5.52%
6,761 $366 Million
Q4 2023

Jan 12, 2024

BUY
$48.48 - $57.85 $9,889 - $11,801
204 Added 2.93%
7,156 $367 Million
Q3 2023

Nov 15, 2023

BUY
$57.89 - $64.73 $231 - $258
4 Added 0.06%
6,952 $404 Million
Q2 2023

Jul 14, 2023

BUY
$63.71 - $70.74 $191 - $212
3 Added 0.04%
6,948 $444 Million
Q1 2023

May 17, 2023

SELL
$65.71 - $74.53 $3,876 - $4,397
-59 Reduced 0.84%
6,945 $481 Million
Q4 2022

Jan 31, 2023

SELL
$68.48 - $81.09 $6,642 - $7,865
-97 Reduced 1.37%
7,004 $14.9 Million
Q3 2022

Nov 09, 2022

SELL
$0.13 - $76.84 $128 - $75,687
-985 Reduced 12.18%
7,101 $14.7 Million
Q2 2022

Jul 15, 2022

BUY
$72.62 - $79.98 $217 - $239
3 Added 0.04%
8,086 $622,000
Q1 2022

Apr 25, 2022

SELL
$61.48 - $73.72 $6,455 - $7,740
-105 Reduced 1.28%
8,083 $590,000
Q4 2021

Feb 15, 2022

SELL
$53.63 - $62.52 $13,461 - $15,692
-251 Reduced 2.97%
8,188 $510,000
Q3 2021

Oct 27, 2021

SELL
$59.17 - $69.31 $16,271 - $19,060
-275 Reduced 3.16%
8,439 $499,000
Q2 2021

Jul 28, 2021

SELL
$61.91 - $67.42 $100,851 - $109,827
-1,629 Reduced 15.75%
8,714 $582,000
Q1 2021

Apr 14, 2021

BUY
$59.34 - $66.74 $69,843 - $78,552
1,177 Added 12.84%
10,343 $652,000
Q4 2020

Jan 15, 2021

SELL
$57.74 - $65.43 $9,989 - $11,319
-173 Reduced 1.85%
9,166 $568,000
Q3 2020

Oct 14, 2020

BUY
$57.43 - $63.64 $134,443 - $148,981
2,341 Added 33.45%
9,339 $563,000
Q2 2020

Jul 21, 2020

SELL
$54.82 - $64.09 $14,198 - $16,599
-259 Reduced 3.57%
6,998 $411,000
Q1 2020

Apr 16, 2020

BUY
$46.4 - $67.43 $3,804 - $5,529
82 Added 1.14%
7,257 $404,000
Q2 2019

Jul 24, 2019

BUY
$44.62 - $49.34 $5,711 - $6,315
128 Added 1.82%
7,175 $325,000
Q4 2018

Feb 05, 2019

SELL
$48.76 - $63.23 $15,798 - $20,486
-324 Reduced 4.4%
7,047 $366,000
Q3 2018

Nov 08, 2018

SELL
$55.19 - $62.25 $204,147 - $230,262
-3,699 Reduced 33.41%
7,371 $458 Million
Q2 2018

Aug 13, 2018

SELL
$50.53 - $62.98 $21,374 - $26,640
-423 Reduced 3.68%
11,070 $0
Q1 2018

Apr 16, 2018

BUY
$59.92 - $68.98 $59 - $68
1 Added 0.01%
11,493 $0
Q4 2017

Feb 15, 2018

SELL
$59.94 - $65.35 $2,337 - $2,548
-39 Reduced 0.34%
11,492 $0
Q3 2017

Nov 13, 2017

BUY
$55.23 - $63.74 $55 - $63
1 Added 0.01%
11,531 $0
Q2 2017

Aug 15, 2017

BUY
N/A
11,530
11,530 $0

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Westside Investment Management, Inc. Portfolio

Follow Westside Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westside Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Westside Investment Management, Inc. with notifications on news.